New Lymphoma clinical trials: 201 posted since Nov 2024

Name: New Lymphoma clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Lymphoma clinical trials: 201 rows for $10.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/lymphoma, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 3, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

201 clinical studies in lymphoma were first posted on ClinicalTrials.gov from November 18, 2024 to November 3, 2026; 37 have an industry sponsor and 173 are recruiting or about to. The newest, NCT07914348, was posted on November 3, 2026: Evaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and... (Leukos Biotech S.L.).

The request: Every new Lymphoma clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

201New trials
37Industry sponsored
173Recruiting or not yet
November 3, 2026Latest posted

Newest trials

The newest 100 of 201, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 3, 2026	NCT07914348	Evaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and Lymphoma	Leukos Biotech S.L.	Phase 1	Recruiting	Solid Tumor Malignancies, Lymphoma	57	Spain	clinicaltrials.gov
November 3, 2026	NCT07912684	The Value of a Tailored-based, Exercise Program for Improving Quality of Life of Patients With Hematologic Malignancies: a Pilot Randomized...	Gruppo Italiano Malattie EMatologiche dell'Adulto	Not applicable	Recruiting	Acute Myeloid Leukemia, Multiple Myeloma, Lymphoma	75	Italy	clinicaltrials.gov
October 26, 2026	NCT07895017	Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell Cytopenias	University of Virginia	Phase 2	Not yet recruiting	Thrombocytopenia	26	United States	clinicaltrials.gov
October 20, 2026	NCT07883941	Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid...	GUSTAVO SALGUERO	Phase 1	Not yet recruiting	Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies, Diffuse Large B Cell Lymphoma...	12		clinicaltrials.gov
October 20, 2026	NCT07883135	Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell Lymphomas	National Research Center for Hematology, Russia	Phase 2	Recruiting	Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Relapsed or Refractory B-cell Lymphoma	40	Russia	clinicaltrials.gov
October 20, 2026	NCT07882576	A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma	AstraZeneca	Observational	Not yet recruiting	Lymphoma, B-Cell	532	Brazil	clinicaltrials.gov
October 20, 2026	NCT07882069	Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia	Selcuk University	Not applicable	Completed	Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience...	70	Turkey (Türkiye)	clinicaltrials.gov
October 15, 2026	NCT07875413	Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell...	AbelZeta Inc.	Phase 2	Not yet recruiting	Large B Cell Lymphoma, LBCL, Diffuse Large B Cell Lymphoma (DLBCL), Relapse Diffuse Large B Cell Lymphoma, High Grade B...	55	United States	clinicaltrials.gov
September 30, 2026	NCT07848672	Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell Mobilization	The Affiliated People's Hospital of Ningbo University	Phase 2/3	Not yet recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Hematopoietic Stem Cell Mobilization...	70		clinicaltrials.gov
September 15, 2026	NCT07820033	Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial	University Health Network, Toronto	Phase 2	Not yet recruiting	Advanced Cancer, Stage IV Solid Tumor Cancer, Stage IV Sarcoma of Bone, Stage IV Lymphoma, Stage IV Melanoma, Endocrine...	46	Canada	clinicaltrials.gov
September 14, 2026	NCT07817641	Proton Therapy for Mediastinal Lymphoma (PROMLY)	Copenhagen University Hospital, Rigshospitalet	Not applicable	Recruiting	Mediastinal Lymphoma, Hodgkin Disease Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)	139	Denmark	clinicaltrials.gov
September 10, 2026	NCT07814170	A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece	University of West Attica	Not applicable	Active not recruiting	Blood Cancers, Leukemia, Lymphoma, Bone Marrow Transplant, Psychological Trauma, Neoplasms, Hematological Malignancies...	80	Greece	clinicaltrials.gov
September 10, 2026	NCT07813585	Impact of Demography, Ethnicity, Co-morbidities and Inequalities on Outcomes in DLBCL Across the UKCHART Network	The Royal Wolverhampton Hospitals NHS Trust	Observational	Not yet recruiting	Lymphoma	2,000		clinicaltrials.gov
September 9, 2026	NCT07810400	A Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed Therapy	Mayo Clinic	Not applicable	Not yet recruiting	Cancer, Lymphoma	470	United States	clinicaltrials.gov
August 28, 2026	NCT07791615	A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2	Not yet recruiting	Lymphoma, NK T-Cell Lymphoma	20		clinicaltrials.gov
August 25, 2026	NCT07785505	Musculoskeletal Ultrasound in Patients With Hematologic Malignancies	Assiut University	Observational	Not yet recruiting	Hematologic Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal Diseases	50		clinicaltrials.gov
August 24, 2026	NCT07782944	CD38 Targeted -PET/ CT for Multiple Myeloma	Guilin Medical University, China	Not applicable	Recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma	100	China	clinicaltrials.gov
August 21, 2026	NCT07779018	CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy	Liping Dou	Phase 2	Recruiting	Lymphoma	30	China	clinicaltrials.gov
August 19, 2026	NCT07774572	Exploration of Circular RNA in B-cell Hematologic Malignancies	Ruijin Hospital	Phase 1	Recruiting	Lymphoma, B-Cell Refractory	30	China	clinicaltrials.gov
August 18, 2026	NCT07771361	BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma	Luminary Therapeutics	Phase 2	Not yet recruiting	Non-Hodgkin Lymphoma Refractory/ Relapsed, Multiple Myeloma Refractory, Multiple Myeloma in Relapse, Non-Hodgkin...	90		clinicaltrials.gov
August 13, 2026	NCT07763054	Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients	Haikou Affiliated Hospital of Central South University Xiangya School of Medicine	Observational	Recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic...	30	China	clinicaltrials.gov
August 7, 2026	NCT07751783	Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations	Kaohsiung Medical University Chung-Ho Memorial Hospital	Not applicable	Recruiting	Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer...	150	Taiwan	clinicaltrials.gov
July 31, 2026	NCT07739849	Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in...	The Clatterbridge Cancer Centre NHS Foundation Trust	Not applicable	Not yet recruiting	Cancer, Lymphoma	200		clinicaltrials.gov
July 20, 2026	NCT07714044	Rutgers University Study of the Genetics of Blood Cancers	Rutgers, The State University of New Jersey	Observational	Recruiting	Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma, Hematologic Cancer, Hematologic Malignancies, Hematologic...	10,000	United States	clinicaltrials.gov
July 17, 2026	NCT07711483	GLORY: Glofit-GemOx With Liso-Cel For Lymphoma	Massachusetts General Hospital	Phase 2	Recruiting	Lymphoma, B-cell Lymphomas, Relapsed/Refractory Large B-cell Lymphoma, Large B-cell Lymphoma	56	United States	clinicaltrials.gov
July 17, 2026	NCT07710781	Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic...	Ossium Health, Inc.	Not applicable	Not yet recruiting	Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic...	300		clinicaltrials.gov
July 15, 2026	NCT07705178	More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL...	University of Erlangen-Nürnberg Medical School	Not applicable	Recruiting	Acute Lymphatic Leukemia, Lymphoma	180	Germany	clinicaltrials.gov
July 13, 2026	NCT07698080	Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific...	Hematology department of the 920th hospital	Phase 2	Not yet recruiting	Leukemia, Lymphoma, Thalassemia, Aplastic Anemia, Myelodysplastic Syndromes	60		clinicaltrials.gov
July 10, 2026	NCT07696169	Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers	Shenzhen Third People's Hospital	Observational	Not yet recruiting	HIV (Human Immunodeficiency Virus), AIDS, Kaposi Sarcoma (KS), Lymphoma, AIDS-Related Malignancy, Lung Cancer in the...	1,000		clinicaltrials.gov
July 9, 2026	NCT07692607	Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant...	LucasBio	Not applicable	Completed	Autologous Hematopoietic Stem Cell Transplant	25	South Korea	clinicaltrials.gov
July 1, 2026	NCT07679919	BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies	Luminary Therapeutics	Phase 1	Not yet recruiting	Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Multiple Myeloma	27	United States	clinicaltrials.gov
June 26, 2026	NCT07670260	GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma	Chinese PLA General Hospital	Early phase 1	Not yet recruiting	Relapsed or Refractory Large B-cell Lymphoma	9	China	clinicaltrials.gov
June 17, 2026	NCT07654426	The CARDIOPROTECT Trial	Beth Israel Deaconess Medical Center	Phase 2	Not yet recruiting	Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, Lymphoma	60	United States	clinicaltrials.gov
June 17, 2026	NCT07652580	Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma	Henry M. Jackson Foundation for the Advancement of Military Medicine	Observational	Recruiting	Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma, Immune Dysregulation	300	United States	clinicaltrials.gov
June 8, 2026	NCT07634263	Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study	Odense University Hospital	Observational	Not yet recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple...	50	Denmark	clinicaltrials.gov
June 5, 2026	NCT07628634	Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors	University of California, Irvine	Early phase 1	Recruiting	Adenocarcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Ductal Carcinoma...	25	United States	clinicaltrials.gov
June 2, 2026	NCT07621887	Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer	The Hong Kong Polytechnic University	Not applicable	Not yet recruiting	Hematologic Cancer, Leukaemia, Lymphoma, Physical Activity	30		clinicaltrials.gov
May 22, 2026	NCT07604987	R-PMDT Regimen in Newly Diagnosed PCNSL	Zou Dehui	Phase 2	Recruiting	Primary Central Nervous System (CNS) Lymphoma	33	China	clinicaltrials.gov
May 14, 2026	NCT07587840	CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma	Liping Dou	Phase 2	Recruiting	Lymphoma	20	China	clinicaltrials.gov
May 13, 2026	NCT07583810	Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone...	City of Hope Medical Center	Phase 2	Recruiting	Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, Marginal...	35	United States	clinicaltrials.gov
May 13, 2026	NCT07583771	A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma	Chipscreen Biosciences, Ltd.	Phase 1	Not yet recruiting	Pancreatic Adenocarcinoma, Non Small Cell Lung Cancer, Advanced Solid Tumors, Lymphoma, Diffuse Large B-Cell Lymphoma...	186	China	clinicaltrials.gov
May 7, 2026	NCT07572175	Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity	Icahn School of Medicine at Mount Sinai	Phase 2	Not yet recruiting	Anthracycline-induced Cardiotoxicity, Lymphoma, Chemotherapy, Cardiotoxicity	60	United States	clinicaltrials.gov
May 5, 2026	NCT07566377	Cord Blood Transplantation in Children and Young Adults With Blood Cancer	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin...	71	United States	clinicaltrials.gov
April 30, 2026	NCT07558057	Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study	Aarhus University Hospital	Observational	Not yet recruiting	Malignant Lymphoma - Lymphoplasmacytic, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma	225	Denmark	clinicaltrials.gov
April 28, 2026	NCT07553572	Remote Monitoring and Symptom Management Digital Application	Patrick C. Johnson, MD	Not applicable	Recruiting	Breast Cancer (Locally Advanced or Metastatic), Lymphoma, Colorectal Cancer	60	United States	clinicaltrials.gov
April 20, 2026	NCT07539610	Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly...	Institute of Hematology & Blood Diseases Hospital, China	Phase 1	Not yet recruiting	B-Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma	9	China	clinicaltrials.gov
April 13, 2026	NCT07524530	Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers	National Cancer Institute (NCI)	Phase 2	Not yet recruiting	Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, Lymphoma	102	United States	clinicaltrials.gov
April 8, 2026	NCT07518329	Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.	Arovella Therapeutics Ltd	Phase 1	Recruiting	Non Hodgkin Lymphoma (NHL), Leukaemia	46	Australia	clinicaltrials.gov
April 6, 2026	NCT07513129	Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell...	M.D. Anderson Cancer Center	Phase 1	Recruiting	T-cell Acute Lymphoblastic Leukemia, Lymphoma	18	United States	clinicaltrials.gov
April 6, 2026	NCT07511426	U96-CAR-T-Cells For R/R B-ALL	The First Affiliated Hospital of Soochow University	Phase 1	Not yet recruiting	Relapsed or Refractory B Cell Leukemia and Lymphoma	30	China	clinicaltrials.gov
April 3, 2026	NCT07509151	Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated...	AstraZeneca	Phase 3	Recruiting	Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV	420	Australia, Canada, Turkey (Türkiye), United Kingdom, United States	clinicaltrials.gov
March 31, 2026	NCT07502872	TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma	Brown University	Phase 2	Not yet recruiting	Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Lymphoma, Lymphoma, B-Cell	30	United States	clinicaltrials.gov
March 30, 2026	NCT07499128	Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event	National Cancer Institute (NCI)	Not applicable	Enrolling by invitation	Cytokine Release Syndrome, Neoplasms, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Multiple Myeloma...	136	United States	clinicaltrials.gov
March 19, 2026	NCT07483749	HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors	The Children's Hospital of Zhejiang University School of Medicine	Observational	Not yet recruiting	Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia, Pediatric	400	China	clinicaltrials.gov
March 17, 2026	NCT07476378	A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Not applicable	Not yet recruiting	Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular, Lymphoma, Mantle-Cell, Chronic Lymphocytic Leukemia...	69	China	clinicaltrials.gov
March 16, 2026	NCT07472972	Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)	University of Zurich	Observational	Recruiting	Lymphoma, Lymphoid Hematological Malignancies	50	Switzerland	clinicaltrials.gov
March 12, 2026	NCT07465835	A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)	Electra Therapeutics Inc.	Phase 1	Recruiting	T Cell Malignancies	84	United States	clinicaltrials.gov
March 9, 2026	NCT07457112	EHealth Educational Intervention to Improve Self-Management and Coping Behaviors Among Cancer Patients	Zagazig University	Not applicable	Completed	Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)	212	Egypt	clinicaltrials.gov
March 6, 2026	NCT07453446	Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	Phase 1	Withdrawn	Relapsed or Refractory Lymphoma	0	China	clinicaltrials.gov
March 2, 2026	NCT07441993	Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL	Institute of Hematology & Blood Diseases Hospital, China	Phase 2	Recruiting	Marginal Zone Lymphoma	30	China	clinicaltrials.gov
February 23, 2026	NCT07426484	Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy	Dana-Farber Cancer Institute	Phase 4	Recruiting	Cutaneous Squamous Cell Carcinoma, Skin Cancer	80	United States	clinicaltrials.gov
February 20, 2026	NCT07422337	A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who...	Arkansas Children's Hospital Research Institute	Observational	Recruiting	B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia, B-Cell Lymphoblastic Leukemia, B-Cell Lymphoblastic...	300	United States	clinicaltrials.gov
February 17, 2026	NCT07412405	This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells...	GUSTAVO SALGUERO	Not applicable	Not yet recruiting	Adult B-cell Acute Lymphoblastic Leukemia, Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell...	12		clinicaltrials.gov
February 13, 2026	NCT07410494	Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors	Essen Biotech	Phase 1/2	Recruiting	Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic), Prostate...	85	China	clinicaltrials.gov
February 5, 2026	NCT07390071	Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy	University of Utah	Not applicable	Recruiting	Lymphoma, Myeloma, Cytokine Release Syndrome, Immune Effector Cell Associated Neurotoxicity Syndrome	40	United States	clinicaltrials.gov
February 3, 2026	NCT07383233	CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma	Qi deng	Phase 1	Not yet recruiting	Lymphoma, CAR T Cell Therapy, Acute Leukemia	18		clinicaltrials.gov
January 21, 2026	NCT07356245	Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma	Ohio State University Comprehensive Cancer Center	Phase 2	Recruiting	T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell, Peripheral T Cell Lymphoma, T-cell Prolymphocytic...	44	United States	clinicaltrials.gov
January 20, 2026	NCT07352267	Diagnostic Value and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy Versus Transbronchial Needle...	China-Japan Friendship Hospital	Not applicable	Not yet recruiting	Mediastinal and Hilar Lymphadenopathy	470		clinicaltrials.gov
January 15, 2026	NCT07343401	Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development	Alexandria University	Observational	Completed	Sarcoidosis Lung	40	Egypt	clinicaltrials.gov
January 12, 2026	NCT07335094	A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic...	Zhujiang Hospital	Early phase 1	Not yet recruiting	B Lymphoblastic Leukemia/Lymphoma	60		clinicaltrials.gov
January 12, 2026	NCT07333469	A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma	Hanx Biopharmaceuticals (Wuhan) Co., Ltd.	Phase 1/2	Not yet recruiting	Solid Tumor and Lymphoma	70		clinicaltrials.gov
January 5, 2026	NCT07316907	A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies	YANRU WANG	Phase 1	Not yet recruiting	Hematologic Malignancies, Lymphoma	12	China	clinicaltrials.gov
December 30, 2025	NCT07309497	Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT...	University of Zurich	Observational	Recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, Geriatric...	208	Switzerland	clinicaltrials.gov
December 29, 2025	NCT07306156	GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms	Zhimin Zhai	Phase 1/2	Recruiting	EBV Associated Lymphoid Neoplasms	24	China	clinicaltrials.gov
December 26, 2025	NCT07305337	Randomised Controlled Trial of Artificial Intelligence-assisted Health Education	Zhongnan Hospital	Not applicable	Recruiting	Leukaemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Lymphoma	196	China	clinicaltrials.gov
December 24, 2025	NCT07302347	A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell...	Merck Sharp & Dohme LLC	Phase 1/2	Recruiting	Malignant Neoplasm, Carcinoma, Merkel Cell, Lymphoma	20	Japan	clinicaltrials.gov
December 22, 2025	NCT07297160	CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors	Baylor College of Medicine	Phase 1	Withdrawn	Lymphoma, Myeloma, Solid Tumors, Sarcoma, Kidney Cancer	0	United States	clinicaltrials.gov
December 19, 2025	NCT07294677	CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL	University of Chicago	Phase 1/2	Recruiting	Leukemia, Lymphoma	104	United States	clinicaltrials.gov
December 18, 2025	NCT07290309	Survivors Uniting for Remote Guided Exercise	Colorado State University	Not applicable	Recruiting	Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Physical Activity...	300	United States	clinicaltrials.gov
December 17, 2025	NCT07289087	Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy	Associazione Qol-one	Observational	Not yet recruiting	Quality of Life, Patient Reported Outcome (PRO), Allogeneic Blood and Marrow Transplantation (BMT), CAR T Cell Therapy	162		clinicaltrials.gov
December 16, 2025	NCT07286539	Precision Physical Exercise for Personalized Onco-Hematology.	University of Salamanca	Not applicable	Not yet recruiting	Hematologic Cancer, Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphocytic Leukemia (CLL), Lung Cancer	150		clinicaltrials.gov
December 16, 2025	NCT07285590	Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma	Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea	Phase 2	Recruiting	Mantle Cell Lymphoma (MCL)	50	Portugal, Spain	clinicaltrials.gov
December 16, 2025	NCT07285174	Shanghai Lymphoma Clinical Cohort	Ruijin Hospital	Observational	Not yet recruiting	Lymphoma, Cohort	1,000		clinicaltrials.gov
December 16, 2025	NCT07284433	Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies	AvenCell Therapeutics, Inc.	Phase 1/2	Recruiting	Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma, Leukemia Relapse, Lymphoma Receiving CAR-T Therapy	178	Germany, United States	clinicaltrials.gov
December 12, 2025	NCT07280494	To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT	Peking University People's Hospital	Phase 1	Recruiting	CD7+ T-ALL/LBL	18	China	clinicaltrials.gov
December 8, 2025	NCT07270263	Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies	Medical University of Gdansk	Not applicable	Recruiting	Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Venous Thromboembolic...	100	Poland	clinicaltrials.gov
December 8, 2025	NCT07268846	Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery	AC Camargo Cancer Center	Not applicable	Recruiting	Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)	164	Brazil	clinicaltrials.gov
December 2, 2025	NCT07259941	PET-CT in Lymphoma Among the Eldery	Assiut University	Observational	Not yet recruiting	PET-CT, Lymphoma, Elderly, Metabolic Parameters	63		clinicaltrials.gov
November 28, 2025	NCT07254754	Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma	Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea	Phase 2	Recruiting	DIFFUSE LARGE B-CELL LYMPHOMA	45	Spain	clinicaltrials.gov
November 25, 2025	NCT07249905	Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma	ModeX Therapeutics, An OPKO Health Company	Phase 1/2	Recruiting	Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma, PMBCL, HGBCL, FL Lymphoma...	180	Australia, Israel, Spain	clinicaltrials.gov
November 24, 2025	NCT07244380	Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.	Hebei Senlang Biotechnology Inc., Ltd.	Phase 2	Not yet recruiting	T Lymphoblastic Leukemia/Lymphoma	38		clinicaltrials.gov
November 12, 2025	NCT07226934	An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers	Washington University School of Medicine	Not applicable	Recruiting	Lymphoma, Multiple Myeloma	40	United States	clinicaltrials.gov
October 28, 2025	NCT07221500	A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor...	Nurix Therapeutics, Inc.	Phase 2	Recruiting	Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)	100	France, Italy, Poland, United Kingdom, United States	clinicaltrials.gov
October 3, 2025	NCT07206264	Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment	Tianjin Medical University Cancer Institute and Hospital	Phase 2	Not yet recruiting	Mantle Cell Lymphoma	45	China	clinicaltrials.gov
October 3, 2025	NCT07205523	High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)	Yigeng Cao,MD,PhD	Observational	Recruiting	Hematopoietic Stem Cell Transplantation (HSCT), Acute Myeloid Leukemia (AML), Leukemias, Acute Myeloid, Myeloid...	1,000	China	clinicaltrials.gov
October 1, 2025	NCT07202091	Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)	Monash University	Phase 2/3	Recruiting	Myeloma, Leukemia, Non Hodgkin's Lymphoma	900	Australia	clinicaltrials.gov
October 1, 2025	NCT07202078	Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)	Monash University	Phase 2/3	Recruiting	Myeloma, Non Hodgkin's Lymphoma, Leukemia	900	Australia	clinicaltrials.gov
October 1, 2025	NCT07202065	Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)	Monash University	Phase 2/3	Recruiting	Myeloma, Non Hodgkin's Lymphoma, Leukemia	900	Australia	clinicaltrials.gov
October 1, 2025	NCT07202052	Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)	Monash University	Phase 2/3	Recruiting	Myeloma, Non-Hodgkin's Lymphoma, Leukemia	900	Australia	clinicaltrials.gov
September 30, 2025	NCT07198958	Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy	IRCCS San Raffaele	Observational	Not yet recruiting	Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Cancer (Solid...	500		clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Memorial Sloan Kettering Cancer Center	5	May 5, 2026
Institute of Hematology & Blood Diseases Hospital, China	5	April 20, 2026
Ruijin Hospital	4	August 19, 2026
Monash University	4	October 1, 2025
IRCCS Azienda Ospedaliero-Universitaria di Bologna	4	February 7, 2025
Assiut University	3	August 25, 2026
Massachusetts General Hospital	3	July 17, 2026
National Cancer Institute (NCI)	3	April 13, 2026
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea	3	December 16, 2025
GUSTAVO SALGUERO	2	October 20, 2026
AstraZeneca	2	October 20, 2026
Mayo Clinic	2	September 9, 2026
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	2	August 28, 2026
Liping Dou	2	August 21, 2026
Luminary Therapeutics	2	August 18, 2026
Ossium Health, Inc.	2	July 17, 2026
Chinese PLA General Hospital	2	June 26, 2026
University of Zurich	2	March 16, 2026
Dana-Farber Cancer Institute	2	February 23, 2026
Essen Biotech	2	February 13, 2026

By phase

Phase	New trials	Latest
Phase 2	45	October 26, 2026
Observational	44	October 20, 2026
Not applicable	42	November 3, 2026
Phase 1	28	November 3, 2026
Phase 1/2	24	February 13, 2026
Phase 2/3	7	September 30, 2026
Early phase 1	7	June 26, 2026
Phase 3	2	April 3, 2026
Phase 4	2	February 23, 2026

By country

Country	New trials	Latest
United States	58	October 26, 2026
China	52	August 24, 2026
Italy	10	November 3, 2026
Australia	9	April 8, 2026
South Korea	7	July 9, 2026
Spain	6	November 3, 2026
Canada	6	September 15, 2026
France	5	October 28, 2025
Denmark	4	September 14, 2026
Germany	4	July 15, 2026
Egypt	3	March 9, 2026
Japan	3	December 24, 2025
Israel	3	November 25, 2025
Mexico	3	August 21, 2025
Brazil	2	October 20, 2026
Turkey (Türkiye)	2	October 20, 2026
Taiwan	2	August 7, 2026
United Kingdom	2	April 3, 2026
Switzerland	2	March 16, 2026
Poland	2	December 8, 2025
Russia	1	October 20, 2026
Greece	1	September 10, 2026
Portugal	1	December 16, 2025
Palestinian Territories	1	September 3, 2025
Hungary	1	July 25, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.